Dermatologic Clinics

Global Dermocosmetic (Skin, Hair) Market Analysis Report 2024: Innovations in Bioengineering Transforming the Industry - Forecasts to 2030 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, April 17, 2024
Cosmetics, Retail, General Health, Health, Online, USD, Market, Supermarket, Sale, Dermatitis, Porter's five forces analysis, Epidemiology, Acne, SWOT, Particulates, Skin, AI, Genetic engineering, John Foster Dulles, Pharmacy, Life, Dermatology, Algorithm, Dehydration, Incidence, Patient, Hyperpigmentation, Psoriasis, Dermatologic Clinics, Rosacea, Child, Beauty, Biological engineering, Urbanization, Ageing, Fermentation, UV, Prevalence, Air pollution, Beauty salon

The market was valued at USD 67.42 Billion in 2023 which is expected to reach USD 108.94 Billion in 2030.

Key Points: 
  • The market was valued at USD 67.42 Billion in 2023 which is expected to reach USD 108.94 Billion in 2030.
  • This report provides a complete analysis for the historical period of 2020-2023, estimates of 2024 and the forecast period of 2025-2030.
  • The report presents the analysis of Dermocosmetic Market for the historical period of 2020-2023, the estimated year 2024 and the forecast period of 2025-2030.
  • Also, the major opportunities, trends, drivers, and challenges of the industry has been analyzed in the report.

Global Hair Removal Market (2022-2027): Easy Availability of Intense Pulsed Light (IPL) Devices Drives Growth - ResearchAndMarkets.com

Retrieved on: 
Tuesday, December 27, 2022
Specialty, Retail, Ansoff Matrix, SWOT, Dermatologic Clinics, USD, Porter's five forces analysis, Risk, Growth, Investment, COVID-19, Dermatology, Observation, Intense, Market development, Geography, Retail, Risk management, Pharmaceutical industry

The Global Hair Removal Market is segmented based on Product, End User, and Geography.

Key Points: 
  • The Global Hair Removal Market is segmented based on Product, End User, and Geography.
  • By Product, the market is classified into Energy-Based Devices, Intense Pulsed Light Devices, and Laser-Based Devices.
  • The report presents a detailed Ansoff matrix analysis for the Global Hair Removal Market.
  • The analyst analyses the Global Hair Removal Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.

Global Aesthetic Medicine Market (2022-2027): Technological Advancements Associated with Medical Aesthetic Devices Presents Opportunities - ResearchAndMarkets.com

Retrieved on: 
Tuesday, November 29, 2022
General Health, Health, Other Health, Growth, Ansoff Matrix, Elective surgery, Hospital, Risk, Non-invasive procedure, USD, Geography, Day, SWOT, Invasive procedure, Dermatologic Clinics, Market development, Investment, Toy, Female, Male, Gender

The Global Aesthetic Medicine Market is estimated to be USD 98.7 Bn in 2022 and is expected to reach USD 157.52 Bn by 2027, growing at a CAGR of 9.80%

Key Points: 
  • The Global Aesthetic Medicine Market is estimated to be USD 98.7 Bn in 2022 and is expected to reach USD 157.52 Bn by 2027, growing at a CAGR of 9.80%
    The Global Aesthetic Medicine Market is segmented based on Type, Gender, End-Users, and Geography.
  • By End-Users, the market is classified into Ambulatory Surgical Center, Beauty Center & Medical Spa, Dermatology Clinic, Home Setting, and Hospital.
  • The report presents a detailed Ansoff matrix analysis for the Global Aesthetic Medicine Market.
  • The analyst analyses the Global Aesthetic Medicine Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.

Global Hair Removal Market to Reach $1.2 Billion by 2027 at a CAGR of 10.44% - ResearchAndMarkets.com

Retrieved on: 
Friday, September 30, 2022
Cosmetics, Retail, Dermatologic Clinics, Customer support, AUD, CHF, Hair removal, Acquisition, Growth, GBP, USD, Dermatology, Decision-making, Strategic management, State, JPY, Use, Intense, CAD, Value, Research, Business Growth Fund, Market share analysis, CAGR, Cryptocurrency, Medical imaging, Retail, EUR

The United States Hair Removal Market size was estimated at USD 680.49 million in 2021, USD 737.94 million in 2022, and is projected to grow at a CAGR 10.44% to reach USD 1,235.22 million by 2027.

Key Points: 
  • The United States Hair Removal Market size was estimated at USD 680.49 million in 2021, USD 737.94 million in 2022, and is projected to grow at a CAGR 10.44% to reach USD 1,235.22 million by 2027.
  • The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF.
  • The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market.
  • It provides the idea of its revenue generation into the overall market compared to other vendors in the space.

Global Laser Hair Removal Market Report 2022: Conventional and Technological Advancement in Aesthetic Lasers Treatment Drives Growth - ResearchAndMarkets.com

Retrieved on: 
Friday, September 30, 2022
Cosmetics, Retail, Alexandrite, Observation, Dermatologic Clinics, Laser, Porter's five forces analysis, COVID-19, Risk, YAG laser, ND, Geography, Growth, Ansoff Matrix, Industry, Market development, USD, Dermatology, SWOT, CAGR, Risk management, Medical device

The Global Laser Hair Removal Market is segmented based on Laser Type, Type, End-user, and Geography.

Key Points: 
  • The Global Laser Hair Removal Market is segmented based on Laser Type, Type, End-user, and Geography.
  • By Laser Type, the market is classified into Alexandrite Laser, Diode Laser and Nd:YAG Laser.
  • The report presents a detailed Ansoff matrix analysis for the Global Laser Hair Removal Market.
  • The report offers a comprehensive evaluation of the Global Laser Hair Removal Market.

Insights on the Tattoo Removal Global Market to 2027 - Rising Demand for Safe and Effective Procedures Presents Opportunities - ResearchAndMarkets.com

Retrieved on: 
Monday, August 29, 2022
Cosmetics, Retail, Specialty, Market development, Observation, Porter's five forces analysis, Impact, USD, Dermatologic Clinics, Radio frequency, Investment, Emotion, Geography, Clinic, SWOT, CAGR, Ansoff Matrix, Competitive analysis, Risk, COVID-19, Dermatology, Growth, Ultrasound, Industry, Pharmaceutical industry, Marketing, Retail, Risk management, Medical device, Medical imaging, Procedure, Laser, Device

The Global Tattoo Removal Market is estimated to be USD 140.84 Mn in 2022 and is projected to reach USD 222.12 Mn by 2027, growing at a CAGR of 9.54%.

Key Points: 
  • The Global Tattoo Removal Market is estimated to be USD 140.84 Mn in 2022 and is projected to reach USD 222.12 Mn by 2027, growing at a CAGR of 9.54%.
  • Market dynamics are forces that impact the prices and behaviors of the Global Tattoo Removal Market stakeholders.
  • The report presents a detailed Ansoff matrix analysis for the Global Tattoo Removal Market.
  • The report analyses the Global Tattoo Removal Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.

HyBryte™ Phase 3 FLASH Study for the Treatment of Cutaneous T-Cell Lymphoma Published in JAMA Dermatology

Retrieved on: 
Wednesday, July 20, 2022
American Medical Association, JAMA Dermatology, JAMA, University, Perelman Center for Advanced Medicine, Lead, Dermatologic Clinics, Fluorescent lamp, NASDAQ, Hospital, Quality of life, Journal, Company, MD, Medical director, Patient, FLASH, Hospital of the University of Pennsylvania, T-cell lymphoma, Pharmaceutical industry, Dermatology, CTCL

The published findings demonstrate that HyBryte treatment statistically significantly reduced lesion size, with the treatment response further improving over successive 6-week treatment cycles.

Key Points: 
  • The published findings demonstrate that HyBryte treatment statistically significantly reduced lesion size, with the treatment response further improving over successive 6-week treatment cycles.
  • JAMA Dermatology is an international peer-reviewed journal published online weekly and in print/ online issue 12 times a year.
  • JAMA Dermatologyis a member of the JAMA Network family of journals, which includesJAMA, 11 JAMA Network specialty journals, andJAMA Network Open.
  • In the first double-blind treatment cycle, 116 patients received HyBryte treatment (0.25% synthetic hypericin) and 50 received placebo treatment of their index lesions.

Outlook on the Macrolide Antibiotics Global Market to 2027 - Focus on Azithromycin, Clarithromycin, Erythromycin, Fidaxomicin and Telithromycin - ResearchAndMarkets.com

Retrieved on: 
Thursday, May 12, 2022
Health, Pharmaceutical, Macrolide, Erythromycin, Bacillary angiomatosis, Azithromycin, Skin, Dermatology, Bordetella pertussis, Government, Food and Drug Administration Safety and Innovation Act, Toxoplasmosis, Infection, Taxation of Chargeable Gains Act 1992, Dermatologic Clinics, The Pew Charitable Trusts, Mycoplasma pneumonia, CAGR, Pew, Clarithromycin, Pfizer, Pig, Pharmaceutical industry, Marketing

The global macrolide antibiotics market is anticipated to grow at a considerable CAGR during the forecast period.

Key Points: 
  • The global macrolide antibiotics market is anticipated to grow at a considerable CAGR during the forecast period.
  • The global macrolide antibiotics market is segmented based on drugs, route of administration, indication and end-user.
  • Analysis of regional regulations and other government policies impacting the global Macrolide antibiotics market.
  • Insights about market determinants that are stimulating the global macrolide antibiotics market.

Dermavant Showcases New Long-Term Data from Phase 3 PSOARING 3 Trial of Tapinarof in Patients with Plaque Psoriasis at the 30th EADV Virtual Congress

Retrieved on: 
Thursday, September 30, 2021
Health, Clinical Trials, Research, Pharmaceutical, Science, Biotechnology, Linda, People, Food, Journal of the European Academy of Dermatology and Venereology, Week, Henry Ford, Efficiency, Dermatologic Clinics, Skin, Patient, NDA, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Therapy, Plaque, Depression, FDA, QD, PGA, Henry Ford Health System, Adult, Hypertension, Vitiligo, Drug discovery, LinkedIn, Diabetes, Twitter, Remittance, Roivant Sciences, Psoriasis, Ageing, Acne, New Drug Application, Risk, Atopic dermatitis, Tachyphylaxis, Research, Maintenance, Obesity, Inflammatory bowel disease, Safety, Quality of life, Doctor of Philosophy, Global Assessment of Functioning, Yale School of Medicine, Pharmaceutical industry, Dermavant’s Phase 3 Program for Tapinarof in Psoriasis, Psoriasis, Dermavant, DERMAVANT’S PHASE 3 PROGRAM FOR TAPINAROF IN PSORIASIS, PSORIASIS, DERMAVANT

The data were presented during a Late-Breaking Session at the 30th European Academy of Dermatology and Venereology (EADV) Virtual Congress.

Key Points: 
  • The data were presented during a Late-Breaking Session at the 30th European Academy of Dermatology and Venereology (EADV) Virtual Congress.
  • Subjects who received tapinarof treatment during PSOARING 1 or 2 and completed PSOARING 3 received treatment for up to 52 weeks.
  • Greater than 90% of eligible patients who completed PSOARING 1 and PSOARING 2 enrolled in PSOARING 3.
  • The company has reported positive Phase 3 results for tapinarof cream in adult patients with plaque psoriasis, and has initiated a Phase 3 program in atopic dermatitis in patients aged 2 years and older.